紫草经线粒体AMPK/ROS通路调控NFAT5改善糖尿病难愈性创面“热气留滞”的作用机制
批准号:
82104862
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
岑璐莎
依托单位:
学科分类:
中医外科学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
岑璐莎
中文摘要
炎症持续是糖尿病创面难愈的主要原因,紫草油清热敛疮,减轻炎症促创面愈合,热气留滞是病机关键。糖尿病是皮肤高渗主要的内在病因,创面发生与高渗密切相关。活化T细胞核因子5(NFAT5)是在高渗下启动并放大炎症的转录因子,高表达于糖尿病致创面难愈。前期研究发现NFAT5在糖尿病早期皮肤及创面高表达,紫草抑制NFAT5。结合线粒体AMPK/ROS通路在调控NFAT5促炎功能中重要作用,我们提出:紫草可经AMPK/ROS选择性抑制NFAT5炎症转录,减少炎症因子释放,使NFAT5恢复生理功能,改善热气留滞促进创面愈合。项目以角质形成细胞、糖尿病鼠创面模型为对象,通过免疫组化等技术,设抑制或过表达组,检测AMPK/ROS/NFAT5通路信号分子变化,揭示紫草油清热敛疮的微观机制。本项目以NFAT5炎症调控热气留滞的新视点揭示紫草促糖尿病创面愈合的机制,异病同治,为紫草在其他高渗相关皮肤病应用提供依据。
英文摘要
Persistent inflammation is the main cause of impaired healing of diabetic wounds. Zicao oil clears heat and collects sores, relieves inflammation and promotes wound healing. Heat retention is the key to pathogenesis. Diabetes mellitus is the main internal cause of skin hyperosmosis, and wound occurrence is closely related to hyperosmosis. Nuclear factor of activated T cells 5 (NFAT5) is a transcription factor that can initiate and amplify inflammation under hyperosmotic stress and is highly expressed in diabetes mellitus,leading to wounds hard healing. Preliminary experiments showed that NFAT5 was highly expressed in early diabetic skin and wounds, and Zicao could inhibit the expression of NFAT5 mRNA and protein. As mitochondrial AMPK/ROS/NFAT5 pathway plays an important role in regulating the pro-inflammatory function of NFAT5, we hypothesized that, through AMPK/ROS/NFAT5 pathway, Zicao could selectively inhibit the transcription region of NFAT5 inflammatory factors, reduce the release of inflammatory factors, alleviate inflammation, restore NFAT5 physiological function, and promote diabetic wound epithelialization. Keratinocytes and diabetic mouse wound models will be taken as research object. Through immunohistochemistry and other techniques, the inhibition or overexpression group will be set, the effects on expression of AMPK/ROS/NFAT5 signaling molecules in diabetic wounds will be studied. The expression changes of AMPK/ROS/NFAT5 signaling molecules in diabetic wounds under different conditions will be detected, so that reveal the mechanism of heat-clearing and sores fetching effect of Zicao oil. This project reveals a novel mechanism of Zicao in treating refractory diabetic wounds from the new perspective of NFAT5 inflammation regulation, and clarifies the relationship between Zicao and hyperosmotic stress mechanism, treating different diseases with same method, which can provide theoretical basis for the application of Zicao in other hyperosmotic-related skin diseases.
本项目背景源于糖尿病皮肤病变的高发及治疗难题,聚焦于糖尿病难愈性创面的治疗机制,以高渗应激调控因子NFAT5为核心靶点,深入探索了紫草在糖尿病皮肤病变中的作用机制。. 主要研究内容包括紫草对高糖下角质形成细胞增殖、迁移及炎症反应的影响,以及紫草对线粒体功能的调控。通过建立高渗HaCaT细胞模型和糖尿病小鼠模型,观察了紫草干预前后细胞增殖、迁移、炎症因子表达、线粒体形态、功能的变化以及紫草经NFAT5/AMPK通路对糖尿病难愈性创面的调控作用。此外,还研究了糖尿病早期皮肤NFAT5/AMPK通路的表达和线粒体功能。. 结果显示:紫草在高渗环境下能有效抑制角质形成细胞的炎症反应,保护线粒体形态和功能完整性,降低ROS水平,提高线粒体膜电位,降低线粒体膜通透性。在糖尿病小鼠模型中,紫草能促进创面愈合,抑制NFAT5蛋白的表达,并通过NFAT5/AMPK通路调节下游分子的表达,包括mTOR、Akt、NF-κB、VEGF、iNOS等。糖尿病小鼠早期病程皮肤NFAT5表达升高。关键数据表明,紫草能显著降低高渗诱导的COX-2表达,保护线粒体免受高渗应激损伤,且在糖尿病小鼠皮肤中,紫草能降低NFAT5和AMPK的表达,促进创面愈合。. 本项目以高渗应激NFAT5为糖尿病难愈性创面靶点具有创新性,为糖尿病皮肤病变的治疗提供了新的视角。其次,以高渗应激NFAT5调控角度解释糖尿病皮肤“热气留滞”病机,丰富了中医对糖尿病皮肤病变的认识。再者,解析了紫草对糖尿病创面线粒体保护功能的具体分子作用机制,为紫草的临床应用提供了理论基础。本项目的研究结果具有临床应用价值和外用新药转化的可能,紫草价格低廉,治疗有效,有望为糖尿病难愈性创面的治疗提供新的解决方案。. 综上所述,本项目通过深入研究紫草对糖尿病难愈性创面的作用机制,不仅揭示了紫草在糖尿病皮肤病变中的治疗潜力,还为紫草的临床应用和新药开发提供了科学依据。
国内基金
海外基金